第一单位:
Centre for Lymphoid Cancer, BC Cancer Agency, Vancouver, BC, Canada.;Institute of Human Genetics, University Medical Center and University of Ulm, Ulm, Germany.
作者:
Anja,Mottok [1]
;
George,Wright [2]
;
Andreas,Rosenwald [3]
;
German,Ott [4]
;
Colleen,Ramsower [5]
;
Elias,Campo [6]
;
Rita M,Braziel [7]
;
Jan,Delabie [8]
;
Dennis D,Weisenburger [9]
;
Joo Y,Song [9]
;
Wing C,Chan [9]
;
James R,Cook [10]
;
Kai,Fu [11]
;
Tim,Greiner [11]
;
Erlend,Smeland [12]
;
Harald,Holte [13]
;
Kerry J,Savage [14]
;
Betty J,Glinsmann-Gibson [5]
;
Randy D,Gascoyne [14]
;
Louis M,Staudt [15]
;
Elaine S,Jaffe [16]
;
Joseph M,Connors [14]
;
David W,Scott [14]
;
Christian,Steidl [14]
;
Lisa M,Rimsza [5]
作者单位:
Centre for Lymphoid Cancer, BC Cancer Agency, Vancouver, BC, Canada.;Institute of Human Genetics, University Medical Center and University of Ulm, Ulm, Germany.
[1]
Biometric Research Program, National Cancer Institute, Rockville, MD.
[2]
Institute of Pathology, University of Würzburg and Comprehensive Cancer Center Mainfranken, Würzburg, Germany.
[3]
Department of Pathology, Robert-Bosch-Krankenhaus and Dr. Margarete Fischer-Bosch Institute for Clinical Pharmacology, Stuttgart, Germany.
[4]
Department of Laboratory Medicine and Pathology, Mayo Clinic, Scottsdale, AZ.
[5]
Hematopathology Unit, Hospital Clinic Barcelona, University of Barcelona, Barcelona, Spain.;Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.
[6]
Department of Pathology, Oregon Health & Science University, Portland, Portland, OR.
[7]
Department of Pathology, University Health Network, Toronto, ON, Canada.
[8]
Department of Pathology, Hematopathology Section and Lymph Node Registry, City of Hope Medical Center, Duarte, CA.
[9]
Department of Laboratory Medicine and Pathology, Cleveland Clinic, Cleveland, OH.
[10]
Department of Pathology, University of Nebraska Medical Center, Omaha, NE.
[11]
Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.;K.G. Jebsen Centre for B Cell Malignancies, Faculty of Medicine, University of Oslo, Oslo, Norway.
[12]
K.G. Jebsen Centre for B Cell Malignancies, Faculty of Medicine, University of Oslo, Oslo, Norway.;Division of Cancer Medicine, Department of Oncology, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.
[13]
Centre for Lymphoid Cancer, BC Cancer Agency, Vancouver, BC, Canada.
[14]
Center for Cancer Research, Lymphoid Malignancies Branch, National Cancer Institute, Bethesda, MD; and.
[15]
Hematopathology Section, National Cancer Institute, Bethesda, MD.
[16]
DOI
10.1182/blood-2018-05-851154
PMID
30257882
发布时间
2024-09-22